+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blepharoplasty Market Size, Share & Industry Trends Analysis Report By Type, By Gender, By End User, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 177 Pages
  • February 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5753011
The Global Blepharoplasty Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 8.0% CAGR during the forecast period.

Sagging eyelids, drooping eyelids, and other irregularities and deformities of the eyelids are often treated by blepharoplasty to enhance the eyes' look and eyesight. In addition, by removing excess fatty deposits, blepharoplasty may reduce puffiness around the eyes. Due to the skin's progressive lack of elasticity, wrinkles and drooping skin around the eyelids are typical indicators of aging. As a result, the market for blepharoplasty is partly influenced by the growing number of people over 65 and their consequent preference for less invasive surgical procedures.



The incidence of visual impairment is increasing as the senior population grows, and blepharoplasty demand is rising along with it. Also, the incidence of visual impairment brought on by diseases like dermatochalasis is rising, which fuels market expansion. Due to visual field problems, dermatochalasis makes it harder to perform basic visual activities, including reading and primary sight.

Moreover, lower eyelid sagging makes it such that the lower eyelashes brush against the eye, causing discomfort, redness, and possibly corneal injury. These problems in the elderly cause more mobility impairment and fewer visual sights. Also, the market is expanding due to the availability of better facilities, the rising demand for cosmetic surgery from the sizable millennial and elderly populations, and the increase in the use of cutting-edge methods and tools.

The significant rise in older adults in nations like China, Brazil, and India, which drive the expansion of the market, has led to an increase in demand for blepharoplasty surgery outside of industrialized countries. Also, the rise in the number of celebrities and the desire for everyone, regardless of gender, to appear attractive has raised the demand for cosmetic procedures like rhinoplasty, blepharoplasty, abdominoplasty, and others, which further fuels the market growth.

COVID-19 Impact Analysis

The widespread of novel coronavirus has hampered operations in the healthcare industry acorss the globe. The COVID-19 pandemic has significantly impacted blepharoplasty surgery market. Strict lockdowns and social segregation policies have been put in place by several nations throughout the globe, which has disrupted access to healthcare facilities and lowered the number of patients choosing to undergo blepharoplasty. The limitations several nations have imposed on elective procedures have hampered the availability of blepharoplasty treatments. Also, the pandemic has resulted in a scarcity of safety gear like gloves and face masks necessary for blepharoplasty operations.

Market Growth Factors

Advancements in the blepharoplasty sector

It is projected that growth would be sparked by the rising frequency of eye-related disorders, especially in the senior population. In addition, the demand for blepharoplasty treatments has increased due to the growth in eye problems such as drooping eyes, blurry vision, and wrinkles around the eyes. Therefore, in the end, demand will rise during the predicted period. Also, the industry is expanding due to consumer desire for improved aesthetics. In addition, because of their many benefits over traditional techniques, doctors are increasingly embracing non-surgical treatments like blepharoplasty. Throughout the foreseeable term, these technological advancements are anticipated to fuel the blepharoplasty market.

More people are using cosmetic treatments

The proliferation of numerous social media platforms results from the accessibility of cell phones, tablets, computers, and internet connectivity. Social media sites like Instagram and YouTube have allowed users to communicate with others all around the globe. Also, social media significantly impacts viewers' adoption of contemporary trends. For example, it has been seen establishing beauty standards for individuals of all genders, including men and women. Women's bodies are depicted on social media as very slender, while men's are portrayed as muscle-bound, scar-free, and flawless. This will fuel the expansion of the blepharoplasty market throughout the projection period.



Market Restraining Factors

Potential blepharoplasty procedure complications

Infection, insomnia, and even modest postoperative trauma are risk factors for postoperative wound dehiscence. Skin sutures with 6-0 prolene imbricating levator or pretarsal tissue are suggested for an upper lid blepharoplasty. Upper lid blepharoplasty results could be better using silk and absorbable sutures. There is a chance of tissue response or dehiscence with absorbable upper lid sutures buried or placed in the skin. Sutures are removed on days 7 or 8 after a CO2 laser incision, which requires 7 days to heal.

Gender Outlook

Based on gender, the blepharoplasty market is segmented into female, and male. The male segment acquired a substantial revenue share in the blepharoplasty market in 2021. This is because males are becoming more conscious of improving their looks, which raises the demand for blepharoplasty surgery. In addition, males are more likely than females to seek blepharoplasty for functional reasons; however, this distinction has been softer over time.

Type Outlook

On the basis of type, the blepharoplasty market is fragmented into upper eyelid blepharoplasty, lower eyelid blepharoplasty, and combination eyelid surgery. In 2021, the upper eyelid blepharoplasty segment held the highest revenue share in the blepharoplasty market. In order to enhance eyesight that was previously obstructed, upper eyelid surgery removes excess skin from the top eyelids and tightens drooping skin. In addition, a smoother forehead and a youthful appearance are a few advantages of this procedure. These are a few of the key reasons influencing the demand for upper eyelid operations around the globe.

End-user Outlook

By End-user, the blepharoplasty market is bifurcated into hospitals, clinics, and ambulatory surgical centre. In 2021, the hospitals segment witnessed the largest revenue share in the blepharoplasty market. This is related to the growth in patients having cosmetic surgery performed at hospitals and the increase in hospitals offering surgical treatments for the eyelid using cutting-edge medical technology.

Regional Outlook

Region wise, the blepharoplasty market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region led the blepharoplasty market by generating highest revenue share. The market is expanding due to the existence of numerous significant key players and the rapid technological progress of medical devices in this area. The main driver of the market's expansion is the rise in the number of individuals having blepharoplasty treatments to enhance the look of their eyes using innovative and sophisticated cosmetic techniques, including laser resurfacing and dermal fillers.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Sisram Medical Ltd (Fosun Pharma), AbbVie, Inc., LightScalpel, Inc, Surgical Holdings, GRAND AESPIO, INC., London Bridge Plastic Surgery, Medline Industries, Inc., and Lumenis Be Ltd.

Scope of the Study

By Type

  • Upper Eyelid
  • Lower Eyelid
  • Combination Eyelid Surgery

By Gender

  • Female
  • Male

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centre

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Sisram Medical Ltd (Fosun Pharma)
  • AbbVie, Inc.
  • LightScalpel, Inc
  • Surgical Holdings
  • GRAND AESPIO, INC.
  • London Bridge Plastic Surgery
  • Medline Industries, Inc.
  • Lumenis Be Ltd.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Blepharoplasty Market, by Type
1.4.2 Global Blepharoplasty Market, by Gender
1.4.3 Global Blepharoplasty Market, by End User
1.4.4 Global Blepharoplasty Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Blepharoplasty Market by Type
3.1 Global Upper Eyelid Market by Region
3.2 Global Lower Eyelid Market by Region
3.3 Global Combination Eyelid Surgery Market by Region
Chapter 4. Global Blepharoplasty Market by Gender
4.1 Global Female Market by Region
4.2 Global Male Market by Region
Chapter 5. Global Blepharoplasty Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Clinics Market by Region
5.3 Global Ambulatory Surgical Centre Market by Region
Chapter 6. Global Blepharoplasty Market by Region
6.1 North America Blepharoplasty Market
6.1.1 North America Blepharoplasty Market by Type
6.1.1.1 North America Upper Eyelid Market by Country
6.1.1.2 North America Lower Eyelid Market by Country
6.1.1.3 North America Combination Eyelid Surgery Market by Country
6.1.2 North America Blepharoplasty Market by Gender
6.1.2.1 North America Female Market by Country
6.1.2.2 North America Male Market by Country
6.1.3 North America Blepharoplasty Market by End User
6.1.3.1 North America Hospitals Market by Country
6.1.3.2 North America Clinics Market by Country
6.1.3.3 North America Ambulatory Surgical Centre Market by Country
6.1.4 North America Blepharoplasty Market by Country
6.1.4.1 US Blepharoplasty Market
6.1.4.1.1 US Blepharoplasty Market by Type
6.1.4.1.2 US Blepharoplasty Market by Gender
6.1.4.1.3 US Blepharoplasty Market by End User
6.1.4.2 Canada Blepharoplasty Market
6.1.4.2.1 Canada Blepharoplasty Market by Type
6.1.4.2.2 Canada Blepharoplasty Market by Gender
6.1.4.2.3 Canada Blepharoplasty Market by End User
6.1.4.3 Mexico Blepharoplasty Market
6.1.4.3.1 Mexico Blepharoplasty Market by Type
6.1.4.3.2 Mexico Blepharoplasty Market by Gender
6.1.4.3.3 Mexico Blepharoplasty Market by End User
6.1.4.4 Rest of North America Blepharoplasty Market
6.1.4.4.1 Rest of North America Blepharoplasty Market by Type
6.1.4.4.2 Rest of North America Blepharoplasty Market by Gender
6.1.4.4.3 Rest of North America Blepharoplasty Market by End User
6.2 Europe Blepharoplasty Market
6.2.1 Europe Blepharoplasty Market by Type
6.2.1.1 Europe Upper Eyelid Market by Country
6.2.1.2 Europe Lower Eyelid Market by Country
6.2.1.3 Europe Combination Eyelid Surgery Market by Country
6.2.2 Europe Blepharoplasty Market by Gender
6.2.2.1 Europe Female Market by Country
6.2.2.2 Europe Male Market by Country
6.2.3 Europe Blepharoplasty Market by End User
6.2.3.1 Europe Hospitals Market by Country
6.2.3.2 Europe Clinics Market by Country
6.2.3.3 Europe Ambulatory Surgical Centre Market by Country
6.2.4 Europe Blepharoplasty Market by Country
6.2.4.1 Germany Blepharoplasty Market
6.2.4.1.1 Germany Blepharoplasty Market by Type
6.2.4.1.2 Germany Blepharoplasty Market by Gender
6.2.4.1.3 Germany Blepharoplasty Market by End User
6.2.4.2 UK Blepharoplasty Market
6.2.4.2.1 UK Blepharoplasty Market by Type
6.2.4.2.2 UK Blepharoplasty Market by Gender
6.2.4.2.3 UK Blepharoplasty Market by End User
6.2.4.3 France Blepharoplasty Market
6.2.4.3.1 France Blepharoplasty Market by Type
6.2.4.3.2 France Blepharoplasty Market by Gender
6.2.4.3.3 France Blepharoplasty Market by End User
6.2.4.4 Russia Blepharoplasty Market
6.2.4.4.1 Russia Blepharoplasty Market by Type
6.2.4.4.2 Russia Blepharoplasty Market by Gender
6.2.4.4.3 Russia Blepharoplasty Market by End User
6.2.4.5 Spain Blepharoplasty Market
6.2.4.5.1 Spain Blepharoplasty Market by Type
6.2.4.5.2 Spain Blepharoplasty Market by Gender
6.2.4.5.3 Spain Blepharoplasty Market by End User
6.2.4.6 Italy Blepharoplasty Market
6.2.4.6.1 Italy Blepharoplasty Market by Type
6.2.4.6.2 Italy Blepharoplasty Market by Gender
6.2.4.6.3 Italy Blepharoplasty Market by End User
6.2.4.7 Rest of Europe Blepharoplasty Market
6.2.4.7.1 Rest of Europe Blepharoplasty Market by Type
6.2.4.7.2 Rest of Europe Blepharoplasty Market by Gender
6.2.4.7.3 Rest of Europe Blepharoplasty Market by End User
6.3 Asia Pacific Blepharoplasty Market
6.3.1 Asia Pacific Blepharoplasty Market by Type
6.3.1.1 Asia Pacific Upper Eyelid Market by Country
6.3.1.2 Asia Pacific Lower Eyelid Market by Country
6.3.1.3 Asia Pacific Combination Eyelid Surgery Market by Country
6.3.2 Asia Pacific Blepharoplasty Market by Gender
6.3.2.1 Asia Pacific Female Market by Country
6.3.2.2 Asia Pacific Male Market by Country
6.3.3 Asia Pacific Blepharoplasty Market by End User
6.3.3.1 Asia Pacific Hospitals Market by Country
6.3.3.2 Asia Pacific Clinics Market by Country
6.3.3.3 Asia Pacific Ambulatory Surgical Centre Market by Country
6.3.4 Asia Pacific Blepharoplasty Market by Country
6.3.4.1 China Blepharoplasty Market
6.3.4.1.1 China Blepharoplasty Market by Type
6.3.4.1.2 China Blepharoplasty Market by Gender
6.3.4.1.3 China Blepharoplasty Market by End User
6.3.4.2 Japan Blepharoplasty Market
6.3.4.2.1 Japan Blepharoplasty Market by Type
6.3.4.2.2 Japan Blepharoplasty Market by Gender
6.3.4.2.3 Japan Blepharoplasty Market by End User
6.3.4.3 India Blepharoplasty Market
6.3.4.3.1 India Blepharoplasty Market by Type
6.3.4.3.2 India Blepharoplasty Market by Gender
6.3.4.3.3 India Blepharoplasty Market by End User
6.3.4.4 South Korea Blepharoplasty Market
6.3.4.4.1 South Korea Blepharoplasty Market by Type
6.3.4.4.2 South Korea Blepharoplasty Market by Gender
6.3.4.4.3 South Korea Blepharoplasty Market by End User
6.3.4.5 Singapore Blepharoplasty Market
6.3.4.5.1 Singapore Blepharoplasty Market by Type
6.3.4.5.2 Singapore Blepharoplasty Market by Gender
6.3.4.5.3 Singapore Blepharoplasty Market by End User
6.3.4.6 Malaysia Blepharoplasty Market
6.3.4.6.1 Malaysia Blepharoplasty Market by Type
6.3.4.6.2 Malaysia Blepharoplasty Market by Gender
6.3.4.6.3 Malaysia Blepharoplasty Market by End User
6.3.4.7 Rest of Asia Pacific Blepharoplasty Market
6.3.4.7.1 Rest of Asia Pacific Blepharoplasty Market by Type
6.3.4.7.2 Rest of Asia Pacific Blepharoplasty Market by Gender
6.3.4.7.3 Rest of Asia Pacific Blepharoplasty Market by End User
6.4 LAMEA Blepharoplasty Market
6.4.1 LAMEA Blepharoplasty Market by Type
6.4.1.1 LAMEA Upper Eyelid Market by Country
6.4.1.2 LAMEA Lower Eyelid Market by Country
6.4.1.3 LAMEA Combination Eyelid Surgery Market by Country
6.4.2 LAMEA Blepharoplasty Market by Gender
6.4.2.1 LAMEA Female Market by Country
6.4.2.2 LAMEA Male Market by Country
6.4.3 LAMEA Blepharoplasty Market by End User
6.4.3.1 LAMEA Hospitals Market by Country
6.4.3.2 LAMEA Clinics Market by Country
6.4.3.3 LAMEA Ambulatory Surgical Centre Market by Country
6.4.4 LAMEA Blepharoplasty Market by Country
6.4.4.1 Brazil Blepharoplasty Market
6.4.4.1.1 Brazil Blepharoplasty Market by Type
6.4.4.1.2 Brazil Blepharoplasty Market by Gender
6.4.4.1.3 Brazil Blepharoplasty Market by End User
6.4.4.2 Argentina Blepharoplasty Market
6.4.4.2.1 Argentina Blepharoplasty Market by Type
6.4.4.2.2 Argentina Blepharoplasty Market by Gender
6.4.4.2.3 Argentina Blepharoplasty Market by End User
6.4.4.3 UAE Blepharoplasty Market
6.4.4.3.1 UAE Blepharoplasty Market by Type
6.4.4.3.2 UAE Blepharoplasty Market by Gender
6.4.4.3.3 UAE Blepharoplasty Market by End User
6.4.4.4 Saudi Arabia Blepharoplasty Market
6.4.4.4.1 Saudi Arabia Blepharoplasty Market by Type
6.4.4.4.2 Saudi Arabia Blepharoplasty Market by Gender
6.4.4.4.3 Saudi Arabia Blepharoplasty Market by End User
6.4.4.5 South Africa Blepharoplasty Market
6.4.4.5.1 South Africa Blepharoplasty Market by Type
6.4.4.5.2 South Africa Blepharoplasty Market by Gender
6.4.4.5.3 South Africa Blepharoplasty Market by End User
6.4.4.6 Nigeria Blepharoplasty Market
6.4.4.6.1 Nigeria Blepharoplasty Market by Type
6.4.4.6.2 Nigeria Blepharoplasty Market by Gender
6.4.4.6.3 Nigeria Blepharoplasty Market by End User
6.4.4.7 Rest of LAMEA Blepharoplasty Market
6.4.4.7.1 Rest of LAMEA Blepharoplasty Market by Type
6.4.4.7.2 Rest of LAMEA Blepharoplasty Market by Gender
6.4.4.7.3 Rest of LAMEA Blepharoplasty Market by End User
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 Sisram Medical Ltd (Fosun Pharma)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Product Line and Regional Analysis
7.2.4 Research & Development Expense
7.3 AbbVie, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 LightScalpel, Inc
7.4.1 Company Overview
7.5 Surgical Holdings
7.5.1 Company Overview
7.6 GRAND AESPIO, INC.
7.6.1 Company Overview
7.7 London Bridge Plastic Surgery
7.7.1 Company Overview
7.8 Medline Industries, Inc.
7.8.1 Company Overview
7.9 Lumenis Be Ltd.
7.9.1 Company Overview

Companies Mentioned

  • Medtronic PLC
  • Sisram Medical Ltd (Fosun Pharma)
  • AbbVie, Inc.
  • LightScalpel, Inc
  • Surgical Holdings
  • GRAND AESPIO, INC.
  • London Bridge Plastic Surgery
  • Medline Industries, Inc.
  • Lumenis Be Ltd.

Methodology

Loading
LOADING...